Puma Biotechnology (PBYI) Revenue Growth (3y) (2020 - 2026)

Puma Biotechnology (PBYI) Revenue Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.73%
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 122.97%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.94%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Puma Biotechnology 384.39 Mn 282.84 Mn 34.39 Mn -5.30%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.30%
Dec 31, 2025 -4.87%
Sep 30, 2025 -1.56%
Jun 30, 2025 -4.13%
Mar 31, 2025 0.20%
Dec 31, 2024 2.19%
Sep 30, 2024 20.31%
Jun 30, 2024 -4.10%
Mar 31, 2024 -23.61%
Dec 31, 2023 11.15%
Sep 30, 2023 3.40%
Jun 30, 2023 -8.22%
Mar 31, 2023 1.00%
Dec 31, 2022 11.68%
Sep 30, 2022 0.44%
Jun 30, 2022 3.35%
Mar 31, 2022 -22.71%
Dec 31, 2021 -8.00%
Sep 30, 2021 -9.61%
Jun 30, 2021 1.69%